Log in
LON:RXB

Rex Bionics Share Forecast, Price & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume314,960 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Rex Bionics Plc is engaged in the research and development, manufacture and commercialization of robotic devices designed to provide physiotherapy to and improve the physical and psychological well-being of people with mobility impairment as a result of spinal cord injury or other neurological trauma, such as stroke or traumatic brain injury, or neurodegenerative disease. The Company develops and commercializes ReX, the hands-free, self-supporting, independently controlled robotic walking device for use in the rehabilitation of people with major mobility impairment. The Company offers two principal products: ReX and ReX P (Personal), which are targeted respectively at the professional neuro-rehabilitation clinic and personal homecare markets. The Company utilizes RAPPER II, which is an open label, single arm, non-randomized, non-comparative registry study of Robot-Assisted Physiotherapy Exercises with the REX Robot powered exercise system preventing unsupported patient ambulation.
Read More
Rex Bionics logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
PhoneN/A
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive RXB News and Ratings via Email

Sign-up to receive the latest news and ratings for RXB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Rex Bionics (LON:RXB) Frequently Asked Questions

Who are Rex Bionics' key executives?

Rex Bionics' management team includes the following people:
  • David John Macfarlane, Chairman of the Board
  • Dominic Crispin Adam Simon, Chief Executive Officer, Director
  • Jeremy Laurence Curnock-Cook, Deputy Chairman of the Board
  • K. M. Robinson, Secretary
  • William L. Hunter M.D., Director
  • Joseph Anthony Cucolo, Non-Executive Director

What is Rex Bionics' stock symbol?

Rex Bionics trades on the London Stock Exchange (LON) under the ticker symbol "RXB."

How do I buy shares of Rex Bionics?

Shares of RXB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Rex Bionics' official website?

The official website for Rex Bionics is www.rexbionicsuk.com.

This page was last updated on 10/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.